English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
Pfizer Acquires Arena Pharmaceuticals for $6.7 Billion
2021-12-21
Pfizer announced on Dec. 13, 2021 that it had entered into a definitive agreement to acquire Arena Pharmaceuticals, a clinical stage company specializing in therapies treating immuno-inflammatory diseases, for $6.7 billion dollars.
QIAGEN Cooperated with AN GREAT (AIT)
2021-12-20
On 17 December 2021, with the support of the Chongqing Municipal Commission of Commerce and Chongqing Customs District P.R.China, QIAGEN China and An Great (AIT) entered into a strategic cooperation to establish the QIAGEN Chongqing Bonded Distribution Centre.
Roche Gets CE Mark for Molecular SARS-CoV-2 Test With Saliva Samples
2021-12-20
Roche announced on Friday that its Cobas SARS-CoV-2 Qualitative test has received CE marking for use with saliva samples.
BD Gets CE Mark, Australian Regulatory Approval for New Cor MX Instrument
2021-12-20
Becton Dickinson announced on Friday that it has received the CE-IVD mark for a new instrument component of its BD Cor system.
Roche Infectious Disease Tests for New Molecular Instrument Nab CE Mark
2021-12-17
Roche announced on Wednesday that four of its molecular infectious disease tests for use on its new Cobas 5800 instrument have received CE marking.
Can Brain Stimulation Help Humanity Fight Climate Change?
2021-12-17
When it comes to climate-friendly behaviour, there is often a gap between what we want and what we actually do. Although most people want to see climate change slowed down, many do not behave in an appropriately sustainable way.
Wondfo Acquires Tisenc Aims to Expand Chemiluminescence Business
2021-12-17
Wondfo Biology Co., Ltd., and Shenzhen Tisenc Medical Device Co., Ltd., a domestic chemiluminescence enterprise, have signed an agreement to acquire 100% equity and corresponding interests of Tisenc medical.
Five China IVD Companies Obtained EU Quality Management System Certificate (IVDR)
2021-12-16
As a "visa" for products to enter the European market, CE certification is a mandatory requirement for product access in the EU market. From May 26, 2022, the European Union will begin to implement the In Vitro Diagnostic Medical Device Regulation EU 2017/746 (IVDR).
FDA Will Consider EUA Submissions for SARS-CoV-2 Variant Genotyping Assays
2021-12-16
The US Food and Drug Administration said on Wednesday that it will consider Emergency Use Authorization submissions for SARS-CoV-2 variant genotyping assays.
Quest Diagnostics Acquires LabTech Diagnostics
2021-12-16
Quest Diagnostics said on Tuesday that it has acquired substantially all of the assets of LabTech Diagnostics.
Hotgen Biotech Acquires 38.0993% Equity of Oriomics for CNY 153 Million
2021-12-15
On December 14, Beijing Hotgen Biotech Co., Ltd. announced that the company intends to acquire 38.0993% equity interest in Oriomics by way of equity transfer and subscription of additional registered capital at a price of CNY 153 million.
Canada regulations news for medical devices and IVDs
2021-12-15
In case you missed it, the Medical Device Regulations in Canada quietly got updated in December 2020. The new regulation intends to boost post-market safety and requires manufacturers to submit a summary report.
CellCarta Acquires Biogazelle
2021-12-15
Canadian precision medicine lab services provider CellCarta has acquired Belgian genomic testing solutions firm Biogazelle. Financial terms of the acquisition were not disclosed.
Ultrarapid Cooling Enables Molecular Patterns of Life To Be Observed
2021-12-14
Fluorescence light microscopy has the unique ability to observe cellular processes over a scale that bridges four orders of magnitude. Yet, its application to living cells is fundamentally limited by the very rapid and unceasing movement of molecules that define its living state.
Baxter Completes Acquisition of Hillrom, Creating ~$15 Billion Global Medtech Leader
2021-12-14
Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of $10.5 billion (based on Hillrom share counts at closing).
Total:
3307
Pages:
221
First
Prev
1
..
140
141
142
143
144
145
146
..
221
Next
End